Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
Abstract Background Pharmaceutical companies in Africa need to invest in both facilities and quality management systems to achieve good manufacturing practice (GMP) compliance. Compliance to international GMP standards is important to the attainment of World Health Organization (WHO) prequalificatio...
Main Authors: | Chimezie Anyakora, Obinna Ekwunife, Faith Alozie, Mopa Esuga, Jonathan Ukwuru, Steve Onya, Jude Nwokike |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12913-017-2610-8 |
Similar Items
-
A Human Perspective of Contractor Prequalification
by: Bassam Michael Baroudi, et al.
Published: (2011-06-01) -
Simple Prequalification Models
by: Plebankiewicz E.
Published: (2010-12-01) -
A Human Perspective of Contractor Prequalification
by: Bassam Michael Baroudi, et al.
Published: (2011-06-01) -
A qualitative assessment of the challenges of WHO prequalification for anti-malarial drugs in China
by: Yangmu Huang, et al.
Published: (2018-04-01) -
Choosing architects for competitions - experiences from the selection of design teams in Sweden
by: Magnus Rönn
Published: (2014-03-01)